265 related articles for article (PubMed ID: 18284638)
1. Too early to dismiss Yersinia enterocolitica infection in the aetiology of Graves' disease: evidence from a twin case-control study.
Brix TH; Hansen PS; Hegedüs L; Wenzel BE
Clin Endocrinol (Oxf); 2008 Sep; 69(3):491-6. PubMed ID: 18284638
[TBL] [Abstract][Full Text] [Related]
2. Yersinia enterocolitica infection does not confer an increased risk of thyroid antibodies: evidence from a Danish twin study.
Hansen PS; Wenzel BE; Brix TH; Hegedüs L
Clin Exp Immunol; 2006 Oct; 146(1):32-8. PubMed ID: 16968395
[TBL] [Abstract][Full Text] [Related]
3. The 19 kDa protein of Yersinia enterocolitica O:3 is recognized on the cellular and humoral level by patients with Yersinia induced reactive arthritis.
Appel H; Mertz A; Distler A; Sieper J; Braun J
J Rheumatol; 1999 Sep; 26(9):1964-71. PubMed ID: 10493678
[TBL] [Abstract][Full Text] [Related]
4. Identification of outer membrane porin f protein of Yersinia enterocolitica recognized by antithyrotopin receptor antibodies in Graves' disease and determination of its epitope using mass spectrometry and bioinformatics tools.
Wang Z; Zhang Q; Lu J; Jiang F; Zhang H; Gao L; Zhao J
J Clin Endocrinol Metab; 2010 Aug; 95(8):4012-20. PubMed ID: 20484489
[TBL] [Abstract][Full Text] [Related]
5. Increased prevalence of antibodies to enteropathogenic Yersinia enterocolitica virulence proteins in relatives of patients with autoimmune thyroid disease.
Strieder TG; Wenzel BE; Prummel MF; Tijssen JG; Wiersinga WM
Clin Exp Immunol; 2003 May; 132(2):278-82. PubMed ID: 12699417
[TBL] [Abstract][Full Text] [Related]
6. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. I. Occurrence of antibodies to Yersinia lipopolisacharydes and Yop proteins by ELISA].
Rastawicki W
Med Dosw Mikrobiol; 2006; 58(4):303-19. PubMed ID: 17642308
[TBL] [Abstract][Full Text] [Related]
7. Role of IFN-gamma and IL-6 in a protective immune response to Yersinia enterocolitica in mice.
Matteoli G; Fahl E; Warnke P; Müller S; Bonin M; Autenrieth IB; Bohn E
BMC Microbiol; 2008 Sep; 8():153. PubMed ID: 18803824
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulins of patients recovering from Yersinia enterocolitica infections exhibit Graves' disease-like activity in human thyroid membranes.
Wolf MW; Misaki T; Bech K; Tvede M; Silva JE; Ingbar SH
Thyroid; 1991; 1(4):315-20. PubMed ID: 1688156
[TBL] [Abstract][Full Text] [Related]
9. No causal relationship between Yersinia enterocolitica infection and autoimmune thyroid disease: evidence from a prospective study.
Effraimidis G; Tijssen JG; Strieder TG; Wiersinga WM
Clin Exp Immunol; 2011 Jul; 165(1):38-43. PubMed ID: 21488870
[TBL] [Abstract][Full Text] [Related]
10. IgA response by oral infection with an attenuated Yersinia enterocolitica mutant: implications for its use as oral carrier vaccine.
Blanco HM; Lacoste MG; Eliçabe RJ; Di Genaro MS
Vaccine; 2008 Dec; 26(51):6497-502. PubMed ID: 18835575
[TBL] [Abstract][Full Text] [Related]
11. [Antibodies to Yersinia enterocolitica in immunogenic thyroid diseases].
Petru G; Stünzner D; Lind P; Eber O; Möse JR
Acta Med Austriaca; 1987; 14(1):11-4. PubMed ID: 3618088
[TBL] [Abstract][Full Text] [Related]
12. [Yersinia enterocolitica. A seroprevalence study and report of 3 clinical cases].
Maltez F; Machado J; Rocha MA; Gonçalves P; Morgado A; Proença R
Acta Med Port; 1993 May; 6(5):223-5. PubMed ID: 8337956
[TBL] [Abstract][Full Text] [Related]
13. Immunogenetic and microbial factors in acute anterior uveitis.
Careless DJ; Chiu B; Rabinovitch T; Wade J; Inman RD
J Rheumatol; 1997 Jan; 24(1):102-8. PubMed ID: 9002019
[TBL] [Abstract][Full Text] [Related]
14. Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies.
Corapçioğlu D; Tonyukuk V; Kiyan M; Yilmaz AE; Emral R; Kamel N; Erdoğan G
Thyroid; 2002 Jul; 12(7):613-7. PubMed ID: 12193307
[TBL] [Abstract][Full Text] [Related]
15. Anti-Yersinia antibodies are not associated with microscopic colitis in an American case-control study.
Tamboli CP; Good MR; Reynolds EM; Sharma P; Mitros FA
Scand J Gastroenterol; 2011 Dec; 46(12):1442-8. PubMed ID: 22017454
[TBL] [Abstract][Full Text] [Related]
16. Bacterial virulence antigens and the pathogenesis of autoimmune thyroid diseases (AITD).
Wenzel BE; Peters A; Zubaschev I
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():75-8. PubMed ID: 8981007
[TBL] [Abstract][Full Text] [Related]
17. Role of β1 integrins and bacterial adhesins for Yop injection into leukocytes in Yersinia enterocolitica systemic mouse infection.
Deuschle E; Keller B; Siegfried A; Manncke B; Spaeth T; Köberle M; Drechsler-Hake D; Reber J; Böttcher RT; Autenrieth SE; Autenrieth IB; Bohn E; Schütz M
Int J Med Microbiol; 2016 Feb; 306(2):77-88. PubMed ID: 26718660
[TBL] [Abstract][Full Text] [Related]
18. Irritable bowel syndrome: a co-twin control analysis.
Wojczynski MK; North KE; Pedersen NL; Sullivan PF
Am J Gastroenterol; 2007 Oct; 102(10):2220-9. PubMed ID: 17897337
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to ubiquitin in relation to Yersinia infection status in patients with ankylosing spondylitis.
Hrycaj P; Łacki JK
Clin Rheumatol; 2003 Feb; 22(1):33-6. PubMed ID: 12605315
[TBL] [Abstract][Full Text] [Related]
20. Yersinia enterocolitica and the chronic fatigue syndrome.
Swanink CM; Stolk-Engelaar VM; van der Meer JW; Vercoulen JH; Bleijenberg G; Fennis JF; Galama JM; Hoogkamp-Korstanje JA
J Infect; 1998 May; 36(3):269-72. PubMed ID: 9661935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
